首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical diabetes and endocrinology

缩写:

ISSN:

e-ISSN:2055-8260

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引206条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Brian M Schmidt,Christine Jarocki Brian M Schmidt
Background: The prevalence of diabetes mellitus continues to rise. Diabetic foot ulcers with osteomyelitis are a diabetes-related complication presenting a significant burden to this cohort. A cure to diabetic foot osteom...
Ekaterina Sorkina,Polina Makarova,Liubov Bolotskaya et al. Ekaterina Sorkina et al.
Background: Congenital generalized lipodystrophy (CGL) is a rare disorder characterized by the lack of adipose tissue and metabolic complications with predominantly autosomal recessive inheritance. There are 6 different g...
Noura Nachawi,Madelyn Lew,Kristine Konopka et al. Noura Nachawi et al.
Background: Thyroid ultrasound is usually used to risk-stratify incidental thyroid nodules. Nodules with high risk sonographic features for malignancy are evaluated by fine-needle aspiration. The role of core needle biops...
Wayne Weng,Ye Tian,Sheldon X Kong et al. Wayne Weng et al.
Background: This study evaluated the impact of atherosclerotic cardiovascular disease (ASCVD) on healthcare resource utilization and costs in patients with type 2 diabetes mellitus (T2DM). ...
Juan Carlos Lizarzaburu-Robles,Juan Carlos Gomez-de-la-Torre,María Del Carmen Castro-Mujica et al. Juan Carlos Lizarzaburu-Robles et al.
[This corrects the article DOI: 10.1186/s40842-019-0091-x.]. © The Author(s). 2020.
Juan Carlos Lizarzaburu-Robles,Juan Carlos Gomez-de-la-Torre,María Del Carmen Castro-Mujica et al. Juan Carlos Lizarzaburu-Robles et al.
Background: Prevalence of maturity-onset diabetes of the young (MODY) is estimated between 1 and 2% of all diabetes cases. In Latin-America little information has been described about the frequency of the disease, perhaps...
Jaime A Davidson,William Stager,Sachin Paranjape et al. Jaime A Davidson et al.
Background: To examine the impact on glycemic control of achieving postprandial glucose (PPG) target with lixisenatide, a once-daily glucagon-like peptide-1 receptor agonist approved in the US, in patients with uncontroll...
Sho Tanaka,Masaru Kushimoto,Tsukasa Nishizawa et al. Sho Tanaka et al.
Background: The programmed cell death 1 (PD-1) inhibitor pembrolizumab is a promising agent for treatment of several different malignancies, but as with all immunotherapy there is a potential risk of immune-related advers...
Christine Jarocki,Brian M Schmidt,Crystal Murray Holmes Christine Jarocki
Background: Diabetes mellitus continues to be a rising concern in the United States. It affects an estimated 9.4% of the population and approximately 1.5 million Americans are diagnosed annually. Approximately 85% of diab...
Raad A Haddad,Gregory A Clines,Jennifer A Wyckoff Raad A Haddad
Background: The heterozygous microdeletion of chromosome 22q11.2 results in a spectrum of disorders, including DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS), with phenotypic features that can include the cl...